Online citations, reference lists, and bibliographies.
← Back to Search

The CD44/integrins Interplay And The Significance Of Receptor Binding And Re-presentation In The Uptake Of RGD-functionalized Hyaluronic Acid.

S. Ouasti, P. J. Kingham, G. Terenghi, N. Tirelli
Published 2012 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We have studied the interplay between two endocytic receptors for a carrier structure bearing two complementary ligands. Hyaluronic acid (HA; three different molecular weights) was functionalized with an RGD-containing peptide; this ancillary ligand allows the macromolecule to bind to α(v) integrins in addition to the classical HA internalization receptor (CD44). The uptake of HA-RGD and of native HA was assessed in a phagocytic cell model (J774.2 murine macrophages), studying the kinetics of internalization and its mechanistic details. Indications of a synergic binding to integrins and CD44 emerged for HA-RGD; possibly, a first binding to integrins allows for a pre-concentration of the macromolecule on the cell surface, which is then followed by its binding to CD44. The endocytic mechanism and kinetics appeared then dominated by CD44, which has a much slower turnover than integrins. In this study we have demonstrated that the knowledge of the rate-determining steps of the internalization of a carrier is necessary for assessing its performance. In this case, the presence of multiple ligands on a carrier was beneficial in some respect (e.g. in improved binding/targeting), but may not be sufficient to overcome penetration barriers that arise from slow receptor re-presentation.
This paper references
10.1002/(SICI)1097-4636(199711)37:2<243::AID-JBM14>3.0.CO;2-F
Crosslinking of hyaluronic acid with water-soluble carbodiimide.
K. Tomihata (1997)
10.1046/J.1523-1747.2000.00194.X
Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus.
G. Kaya (2000)
10.1038/sj.leu.2400653
Activation of β1 integrins on CML progenitors reveals cooperation between β1 integrins and CD44 in the regulation of adhesion and proliferation
B I Lundell (1997)
Association of intracellular osteopontin with the CD44 receptor complex in osteoclasts
K Suzuki (2000)
10.1163/156856208X393518
Uptake of Enzymatically-Digested Hyaluronan by Liver Endothelial Cells in Vivo and in Vitro
S. Mochizuki (2009)
10.1016/0960-7404(93)90015-Q
CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen.
S. Ishii (1993)
10.1186/gb-2007-8-5-215
The integrins
Y. Takada (2007)
10.1126/SCIENCE.278.5338.672
Requirement for CD44 in activated T cell extravasation into an inflammatory site.
H. Degrendele (1997)
10.1002/jlb.56.5.605
Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages
M. Culty (1994)
10.1161/01.RES.88.1.77
Hyaluronan Enhances Contraction of Collagen by Smooth Muscle Cells and Adventitial Fibroblasts: Role of CD44 and Implications for Constrictive Remodeling
J. A. Travis (2001)
10.1242/jcs.022038
Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
C. Maxwell (2008)
10.1074/JBC.274.4.2511
Characterization of the Heparan Sulfate and Chondroitin Sulfate Assembly Sites in CD44*
B. Greenfield (1999)
10.1083/jcb.200511027
Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
C. Tolg (2006)
10.1101/GAD.11.8.996
Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation.
G. Kaya (1997)
10.1002/dvdy.21605
Expression of the hyaluronan receptor LYVE‐1 is not restricted to the lymphatic vasculature; LYVE‐1 is also expressed on embryonic blood vessels
Emma J Gordon (2008)
Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers
有元 純子 (2009)
10.1016/S1074-7613(04)00077-9
Bimolecular complex between rolling and firm adhesion receptors required for cell arrest; CD44 association with VLA-4 in T cell extravasation.
A. Nandi (2004)
10.1074/JBC.M103481200
Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism*
R. Tammi (2001)
10.1242/jcs.00407
TSG-6: a multifunctional protein associated with inflammation
C. Milner (2003)
10.1016/S0960-9822(01)00442-0
PDGF-regulated rab4-dependent recycling of αvβ3 integrin from early endosomes is necessary for cell adhesion and spreading
M. Roberts (2001)
10.1038/nrm2799
Integrins: masters and slaves of endocytic transport
P. Caswell (2009)
10.1074/jbc.M702889200
Inflammation-induced Uptake and Degradation of the Lymphatic Endothelial Hyaluronan Receptor LYVE-1*♦
L. A. Johnson (2007)
10.1074/JBC.M311838200
CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion*
L. Bourguignon (2004)
10.1084/JEM20313OIA31
Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.
C. Tolg (2006)
A CellSurfaceChondroitin SulfateProteoglycan, Immunologically RelatedtoCD44, IsInvolvedin Type ICollagen-mediated Melanoma CellMotilityand Invasion
A. E. Faassen (1992)
10.1080/10428190600709721
Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia
K. Giannopoulos (2006)
10.1002/mabi.201100156
Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.
N. M. Zaki (2011)
10.1083/JCB.116.3.817
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin
S. Jalkanen (1992)
10.1046/j.1365-3083.1999.00638.x
Beta1‐Integrins Control Spontaneous Adhesion and Motility of Human Progenitor Thymocytes and Regulate Differentiation‐Dependent Expression of the Receptor for Hyaluronan‐Mediated Motility
Gares (1999)
Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate.
L. Esford (1998)
10.1046/J.0022-202X.2004.22205.X
Fibroblast invasive migration into fibronectin/fibrin gels requires a previously uncharacterized dermatan sulfate-CD44 proteoglycan.
R. Clark (2004)
Preparation and properties of fluorescein-labeled hyaluronate
AN Debelder (1975)
10.2174/138920108785161514
The development of hyaluronan as a drug transporter and excipient for chemotherapeutic drugs.
T. Brown (2008)
10.1074/jbc.M110.137562
Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane System
P. Wolny (2010)
10.1007/s10815-008-9268-4
Hyaluronan in follicular fluid and embryo implantation following in vitro fertilization and embryo transfer
A. Babayan (2008)
Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA.
E. Choi (1994)
10.1006/EXCR.1999.4641
Internalization of the hyaluronan receptor CD44 by chondrocytes.
D. J. Aguiar (1999)
10.1006/CIMM.1998.1397
Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and foskolin differentially regulate the binding of CD44 to hyaluronic acid.
D. Liu (1998)
10.1007/s11095-009-9908-0
Chitosan/TPP and Chitosan/TPP-hyaluronic Acid Nanoparticles: Systematic Optimisation of the Preparative Process and Preliminary Biological Evaluation
A. Nasti (2009)
responses through interaction with Cd 44
B Greenfield (1993)
10.1016/0006-291X(82)92101-5
Purification of a hyaluronate-binding protein fraction that modifies cell social behavior.
E. Turley (1982)
10.1016/S0142-9612(98)00042-8
Semisynthetic resorbable materials from hyaluronan esterification.
D. Campoccia (1998)
Binding of CD 44 to hyaluronic acid can be induced by multiple signals and requires the CD 44 cytoplasmic domain
DC Liu (1996)
10.1128/MCB.00186-08
CD44 Engagement Promotes Matrix-Derived Survival through the CD44-SRC-Integrin Axis in Lipid Rafts
Jia-Lin Lee (2008)
10.1074/jbc.R100036200
Hyaluronan-binding Proteins: Tying Up the Giant*
A. J. Day (2002)
10.1016/0092-8674(93)90417-O
The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44
M. F. Naujokas (1993)
Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen.
A. Faassen (1993)
10.4049/jimmunol.167.9.5367
Role of Sulfation in CD44-Mediated Hyaluronan Binding Induced by Inflammatory Mediators in Human CD14+ Peripheral Blood Monocytes1
K. Brown (2001)
10.1084/jem.20071765
Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids
Braedon McDonald (2008)
10.1083/JCB.114.5.1089
An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3- mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation
S. Massia (1991)
10.1016/S0945-053X(01)00186-X
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
10.1016/S0142-9612(02)00420-9
Photopolymerized hyaluronic acid-based hydrogels and interpenetrating networks.
Y. D. Park (2003)
10.1083/JCB.126.4.1099
Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function
V. Lokeshwar (1994)
10.1111/j.1742-4658.2011.08071.x
Hyaluronan–CD44 interactions as potential targets for cancer therapy
S. Misra (2011)
10.1002/BIT.260150410
Preparation and properties of an immobilized Barley β‐amylase
P. Vretblad (1973)
Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells
Laura Contreras-Ruiz (2011)
10.1517/17425247.2010.501792
Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting
N. M. Zaki (2010)
10.1074/JBC.M313319200
TSG-6 Modulates the Interaction between Hyaluronan and Cell Surface CD44*[boxs]
J. Lesley (2004)
10.1074/jbc.M607787200
Expression, Processing, and Glycosaminoglycan Binding Activity of the Recombinant Human 315-kDa Hyaluronic Acid Receptor for Endocytosis (HARE)*
E. N. Harris (2007)
10.1097/BLO.0b013e31805c6eae
Erratum: Viscosupplementation for knee osteoarthritis: A systematic review (Clinical Orthopaedics and Related Research (2007) 455, (113-122))
P. Diviné (2007)
10.1074/jbc.M601530200
Acylation of CD44 and Its Association with Lipid Rafts Are Required for Receptor and Hyaluronan Endocytosis*
Sai P. Thankamony (2006)
10.1074/JBC.M405322200
Endocytic Function, Glycosaminoglycan Specificity, and Antibody Sensitivity of the Recombinant Human 190-kDa Hyaluronan Receptor for Endocytosis (HARE)*
E. N. Harris (2004)
10.1021/BC00010A007
Chemical modification of hyaluronic acid by carbodiimides.
J. W. Kuo (1991)
10.1084/JEM.182.2.419
Glycosylation of CD44 negatively regulates its recognition of hyaluronan
S. Katoh (1995)
10.1016/J.IT.2005.09.009
Hyaluronan cross-linking: a protective mechanism in inflammation?
A. J. Day (2005)
10.1016/S0741-5214(94)70127-X
Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA
E. Choi (1994)
10.1002/MABI.200600041
Investigating the interactions of hyaluronan derivatives with biomolecules. The use of diffusional NMR techniques.
A. Taglienti (2006)
10.1083/JCB.116.4.1055
The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan
M. Culty (1992)
10.1074/JBC.M907962199
Oncostatin M and Transforming Growth Factor-β1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells*
J. Cichy (2000)
10.1158/0008-5472.CAN-06-3625
Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Jia-Lin Lee (2007)
10.1002/JCP.1041330210
Size‐dependent hyaluronate degradation by cultured cells
P. G. Mcguire (1987)
10.1006/CIMM.1996.0295
Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
D. Liu (1996)
10.1074/jbc.M608358200
CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2*
Hosami Harada (2007)
10.1016/S0008-6215(00)84168-3
Preparation and properties of fluorescein-labelled hyaluronate.
A. de Belder (1975)
10.1002/ADMA.200304621
Cell-responsive synthetic hydrogels
M. Lutolf (2003)
10.1016/S0955-0674(00)00135-6
Hyaluronan: a multifunctional, megaDalton, stealth molecule.
J. Lee (2000)
PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions.
A. Woods (2004)
10.1038/nm.1941
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
A. Reynolds (2009)
10.1074/jbc.M111.247395
The Inflammation-associated Protein TSG-6 Cross-links Hyaluronan via Hyaluronan-induced TSG-6 Oligomers
N. S. Baranova (2011)
10.1016/J.JMB.2007.03.003
A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.
Gaël Vidricaire (2007)
10.1016/J.JCONREL.2007.02.011
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
H. Lee (2007)
10.1016/J.CEB.2006.08.003
Endocytic recycling pathways: emerging regulators of cell migration.
Matthew C. Jones (2006)
10.1074/jbc.M108654200
A Requirement for the CD44 Cytoplasmic Domain for Hyaluronan Binding, Pericellular Matrix Assembly, and Receptor-mediated Endocytosis in COS-7 Cells*
H. Jiang (2002)
10.1182/blood-2010-05-280115
Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP?
A. Crow (2011)
10.1021/BC9900338
Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate.
Y. Luo (1999)
10.1074/JBC.M011004200
Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic Endothelium*
R. Prevo (2001)
Viscosupplementation: a new concept in the treatment of osteoarthritis.
E. Balazs (1993)
10.1002/j.1460-2075.1994.tb06261.x
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
B. Yang (1994)
10.1038/sj.emboj.7600267
PKD1/PKCμ promotes αvβ3 integrin recycling and delivery to nascent focal adhesions
A. Woods (2004)



This paper is referenced by
10.1002/adhm.201901182
Binding and Internalization in Receptor-Targeted Carriers: The Complex Role of CD44 in the Uptake of Hyaluronic Acid-Based Nanoparticles (siRNA Delivery).
Julio M Rios de la Rosa (2019)
10.3390/pharmaceutics12030260
On-Chip Synthesis of Hyaluronic Acid-Based Nanoparticles for Selective Inhibition of CD44+ Human Mesenchymal Stem Cell Proliferation
E. Chiesa (2020)
10.1177/0885328217712110
Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy
Y. Guo (2017)
10.1021/mp500129t
Light-triggered, efficient cytosolic release of IM7-saporin targeting the putative cancer stem cell marker CD44 by photochemical internalization.
Monica Bostad (2014)
10.1007/s11095-014-1393-4
Hyaluronan-Based Nanocarriers with CD44-Overexpressed Cancer Cell Targeting
Shuangshuang Song (2014)
10.1039/C6RA27364E
The synergistic effect of type I collagen and hyaluronic acid on the biological properties of Col/HA-multilayer-modified titanium coatings: an in vitro and in vivo study
Haiyong Ao (2017)
10.1021/acs.molpharmaceut.7b00320
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.
E. Lallana (2017)
10.1007/s11595-017-1774-8
Preparation and characterization of an intelligent multi-target tracking HA-RGD-CLB-QDs drug delivery system
Fengzheng Wu (2017)
10.1016/j.jconrel.2015.05.274
Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: A mechanistic insight.
H. Ragelle (2015)
10.1016/j.msec.2017.04.137
pH-triggered degradable polymeric micelles for targeted anti-tumor drug delivery.
L. Qiu (2017)
10.1038/s41598-020-71396-x
Microfluidic-assisted preparation of RGD-decorated nanoparticles: exploring integrin-facilitated uptake in cancer cell lines
Julio M Rios de la Rosa (2020)
DEVELOPMENT OF INNOVATIVE FORMULATIONS BASED ON POLYSACCHARIDES FOR TUMOR TREATMENT
Simona Giarra (2017)
10.2478/pjct-2019-0041
The separation of microscale HA in aqueous solution by foam separation technique
Shao Wenyao (2019)
10.3762/bjnano.10.250
The different ways to chitosan/hyaluronic acid nanoparticles: templated vs direct complexation. Influence of particle preparation on morphology, cell uptake and silencing efficiency
A. Gennari (2019)
10.1002/mabi.201600311
Hyaluronan/Tannic Acid Nanoparticles Via Catechol/Boronate Complexation as a Smart Antibacterial System.
E. Montanari (2016)
10.1016/j.jconrel.2013.09.032
Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Abdulaziz Almalik (2013)
Hyaluronic acid-coated nanoparticles as biofunctional pharmaceutical carriers
Abdulaziz Almalik (2013)
10.1002/mabi.201700214
Butyrate-Loaded Chitosan/Hyaluronan Nanoparticles: A Suitable Tool for Sustained Inhibition of ROS Release by Activated Neutrophils.
Pasquale Sacco (2017)
10.2147/IJN.S111950
Decoration of pH-sensitive copolymer micelles with tumor-specific peptide for enhanced cellular uptake of doxorubicin
Q. Chen (2016)
10.1155/2015/586290
Isolation, Culture, and Characterization of Chicken Cartilage Stem/Progenitor Cells
Lu Li (2015)
10.1208/s12249-018-1256-0
Stability, Cytotoxicity, and Retinal Pigment Epithelial Cell Binding of Hyaluronic Acid-Coated PLGA Nanoparticles Encapsulating Lutein
Chuda Chittasupho (2018)
10.1021/acsami.5b04216
Layer-by-Layer (LBL) Self-Assembled Biohybrid Nanomaterials for Efficient Antibacterial Applications.
Yuanhao Wu (2015)
10.1039/d0cc01848a
Dual-targeting RNA nanoparticles for efficient delivery of polymeric siRNA to cancer cells.
Taehyung Kim (2020)
10.1186/s10020-020-00204-z
FK506 induces lung lymphatic endothelial cell senescence and downregulates LYVE-1 expression, with associated decreased hyaluronan uptake
S. Shrestha (2020)
10.5772/67779
Dendritic Cell Endocytosis Essential for Viruses and Vaccines
K. Mccullough (2017)
10.1016/j.msec.2017.08.002
Dual targeting hyaluronic acid - RGD mesoporous silica coated gold nanorods for chemo-photothermal cancer therapy.
H. Zhou (2017)
10.1007/s11595-018-1853-4
Hyaluronic Acid-RGD Peptide Conjugated Mesoporous Silica-coated Gold Nanorods for Cancer Dual-targeted Chemo-photothermal Therapy
Huimin Zhou (2018)
10.1039/c3nr90022c
Development of drug loaded nanoparticles for tumor targeting. Part 2: Enhancement of tumor penetration through receptor mediated transcytosis in 3D tumor models.
M. El-Dakdouki (2013)
10.3109/10520295.2013.831485
Research potential of multi-lineage chicken amniotic mesenchymal stem cells
X. Li (2014)
10.18632/AGING.100438
Genome integrity, stem cells and hyaluronan
Z. Darzynkiewicz (2012)
10.1016/j.cej.2020.126891
CXCR4 and CD44 Dual-Targeted Prussian Blue Nanosystem with Daunorubicin Loaded for Acute Myeloid Leukemia Therapy
Huiyuan Bai (2021)
10.1021/bm302003m
Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection.
Grit Baier (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar